Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterActive in the last 2 years

Syed Mohammad Ali Kazmi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3367-367X; OpenAlex author ID A5086948150. Sources: ClinicalTrials.gov.

Their work

Papers
5
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2019: 1 trial · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 5

  1. Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial. Co-author DOI 10.1038/s41591-026-04734-7↗
  2. Post-operative patterns of failure and outcomes reveal opportunities to optimize treatment of recurrent pancreatic cancer Co-author DOI 10.1101/2025.11.08.25339815↗
  3. Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-3582↗
  4. Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes. Co-author DOI 10.1016/j.ijrobp.2022.07.019↗
  5. Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer. Co-author DOI 10.1097/coc.0000000000000802↗

Trials 1

  1. Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer Principal investigator NCT03649321↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nina Niu Sanford · 4 shared papers, 2021–2025 · strength 0.66
  2. Patricio Marcelo Polanco · 3 shared papers, 2022–2025 · strength 0.54
  3. Ahmed M. Elamir · 3 shared papers, 2022–2025 · strength 0.54
  4. Todd Anthony Aguilera · 3 shared papers, 2022–2025 · strength 0.54
  5. Matthew R. Porembka · 3 shared papers, 2022–2025 · strength 0.54
  6. Herbert J. Zeh · 3 shared papers, 2022–2025 · strength 0.54
  7. Muhammad Shaalan Beg · 3 shared papers, 2021–2025 · strength 0.43
  8. Peter Q. Leung · 2 shared papers, 2025 · strength 0.41
  9. Salwan S. Al Mutar · 2 shared papers, 2025 · strength 0.41
  10. John Michael P. Tomagan · 1 shared paper, 2025 · strength 0.23
  11. Shahed Nicolas Badiyan · 1 shared paper, 2025 · strength 0.23
  12. Harshabad Singh · 1 shared paper, 2026 · strength 0.19
  13. Zev A. Wainberg · 1 shared paper, 2026 · strength 0.19
  14. Jennifer Brooke Valerin · 1 shared paper, 2026 · strength 0.19
  15. Naomi H. Fei · 1 shared paper, 2026 · strength 0.19
  16. Alexis Diane Leal · 1 shared paper, 2026 · strength 0.19
  17. Andrew Eugene Hendifar · 1 shared paper, 2026 · strength 0.19
  18. Craig Devoe · 1 shared paper, 2026 · strength 0.19
  19. Jonathan D. Mizrahi · 1 shared paper, 2026 · strength 0.19
  20. Pashtoon Murtaza Kasi · 1 shared paper, 2026 · strength 0.19
  21. Eileen Mary O'Reilly · 1 shared paper, 2026 · strength 0.19
  22. Ben George · 1 shared paper, 2026 · strength 0.19
  23. Peter J. Hosein · 1 shared paper, 2026 · strength 0.19
  24. Manuel M. Hidalgo · 1 shared paper, 2026 · strength 0.19
  25. Dana Backlund Cardin · 1 shared paper, 2026 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.